Quest Diagnostics 2000 Annual Report Download - page 10
Download and view the complete annual report
Please find page 10 of the 2000 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2 -
3 -
4 -
5 -
6 -
7 -
8 -
9 -
10 -
11 -
12 -
13 -
14 -
15 -
16 -
17 -
18 -
19 -
20 -
21 -
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
 |
 |
8
Thomas Merigan, M.D.
Hasnah Hamdan, Ph.D.
Director, Center for AIDS Research
Stanford University School of Medicine
Stanford, California
Scientific Director, Molecular Microbiology
Quest Diagnostics Nichols Institute
In 2000, Thomas Merigan, M.D., Director of the Center for AIDS Research at Stanford University, and scientists at our
Nichols Institute identified a new mutation of HIV-1 that is associated with reduced susceptibility to antiviral drugs, giving
physicians additional information to better target effective treatment. Our association with Dr. Merigan has produced
several other developments in HIV testing, including the world’s first HIV resistance test. “This collaboration between
academia and industry makes available the best technology anywhere to doctors everywhere,” Dr. Merigan says. “It’s a
unique approach that has enabled us to give something really special to the whole world.”
Innovative Results